Instructions for Authors

Submit your article

Our Journal uses certified plagiarism checker softwares (iThenticate® and Grammarly®) to verify the authenticity of articles and detect duplications from each article content online against billions of web pages.

 

JOURNAL ISSN (ONLINE VERSION) 2372-3416

World Cancer Research Journal (WCRJ) is an open-access journal. It upholds a peer-reviewed, rapid, and rigorous original manuscript handling and editorial process. It publishes Editorials, Reviews, Original Papers, and Scientific Correspondence on subjects regarding all areas of cancer: basic cancer research, cancer prevention, translational research, environment and cancer, lifestyle and cancer, pharmacology and pharmacogenomics aspects, cancer treatments, elderly cancer patients, virus-related tumors, cancer survivorship, psycho-oncology; innovative aspects regarding diagnosis, pathology, clinical-experimental oncology. WCRJ is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety, and meta-analyses. Reviews should include systematic revision of the literature concerning the treated topics and preferably meta-analyses, original illustrations, and tables. WCRJ doesn’t accept for the publication “data not shown” or “unpublished data”. Letters are restricted to the discussion of papers already published in the journal, with a maximum of 300 words, one table or figure and up to ten references.

Short Reports and Case Reports will be considered for publication only if of particular interest. The structured abstract must not exceed 200 words.


Article Processing Charges (APCs)

This journal does not charge APCs or submission charges. No fee is required to publish in our Journal.

 

Manuscript Submission

Authors should submit manuscripts including figures to the WCRJ – Please read and apply the loading instructions given at this site, noting that all information entered during the submission process related to the manuscript should also be included, and be identical to the final submitted version of the manuscript – please see full details under “Presentation of Manuscripts”. It is essential that authors could provide all supplementary information required to understand and verify the research presented in the article. Submitted papers should be well formatted in grammatically correct English. Papers must be submitted exclusively to the Journal, and are accepted on the understanding that they have not been, and will not be, published elsewhere. The correspondence for each article must be followed only by the corresponding author. The submission process requires a full declaration of personal interests of all Authors, and funding interests; these details should also be included in the text of the manuscript (see below).

Please note that the journal employs a plagiarism detection system. By submitting your manuscript to the journal you accept that your manuscript may be screened for plagiarism against previously published work.

Authorship

Authors must fulfill the following criteria:

  • He/she must have made a substantial contribution to research design, or to the acquisition, analysis or interpretation of data;
  • He/she must have drafted the paper or revised it critically;
  • He/she must have given approval of the submitted and final versions

Copyright Transfer Agreement: WCRJ Authors will be required to sign a Copyright Transfer Agreement (click to download PDF) for all papers accepted for publication. Signature of the CTA is a condition of publication and papers will not be passed to the publisher for production unless a signed form has been received. After submission, Authors cannot submit their manuscript to other journals. After acceptance, the Publisher got the rights and became the owner of the paper. To assist Authors, an appropriate CTA form will be supplied by the editorial office. The original completed Copyright Transfer Agreement must be signed by the corresponding Author and sent by e-mail to WCRJ. The Editors retain the usual right to modify the style and length of a contribution (major changes being agreed with the corresponding Author) and to decide the time of publication.

Licensing

WCRJ applies the Creative Commons Attribution (CC BY-NC-SA 4.0) license to articles. If you submit your paper for publication to our journal, you agree to have the CC BY-NC-SA 4.0 license applied to your work as follows:

BY) Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NC) NonCommercial — You may not use the material for commercial purposes.

SA) ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

No additional restrictions) You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices: you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

 

Presentation of Manuscripts

A title page must contain the Authors’ names, appointments and place of work at the relevant time, plus the full contact details of the Corresponding Author including their current e-mail address. A full and a short running title should be given, together with a small number of keywords for indexing purposes.

The text should start with a structured Abstract, not exceeding 270 words, organized into sections using all of the following headings INTRODUCTION or BACKGROUND or OBJECTIVE, PATIENTS AND METHODS or MATERIALS AND METHODS, RESULTS, CONCLUSIONS. The paper should then proceed conventionally: Introduction, Background or Background or Objective, Patients and Methods or Materials and Methods, Results, Discussion, Conclusions, and References. Pages should be numbered consecutively in Arabic numerals, including tables, figure legends (with magnifications if needed), acknowledgments, and declaration of interests. Review Articles and Systematic Reviews also require a structured summary using all of the following headings: INTRODUCTION or BACKGROUND or OBJECTIVE, PATIENTS AND METHODS or MATERIALS AND METHODS (e.g., search terms used), RESULTS (avoid vague statements e.g. ‘…will be discussed’), CONCLUSIONS (e.g., need for future studies).

References must be numbered in the order in which they are first mentioned in the text, and should be identified in the text, tables, and legends by Arabic numbers in superscript. The US National Library of Medicine and used in Index Medicus applies (for more details see the section “References”). References must be verified by the Authors against the original documents.

Authors who want to publish on our Journal must follow the guidelines on Good Publication Practice: COPE https://publicationethics.org/resources/guidelines and PERK http://jp.elsevier.com/_old/editors/perk. These guidelines aim to ensure that articles are published in a responsible and ethical manner.

References

This section has to include the most recent studies that have been done on that topic.

When reporting the reference numbers in the text, you must follow these rules: “1-2” must be written as “1,2” and so on. You have to put “-“ just in case you have many consecutive numbers. For example: “1,2,3,4,5,6” must be written as “1-6”;

References’ numbers must follow a chronological order within the text and must be inserted before the punctuation. (YES 12. NO.12)

Complete all the references in accordance with the Instructions for the authors (see How to submit an article, https://www.wcrj.net/instructions-for-authors): list all the authors (NOT et al), year without month of publication, delete the number of the single issue after the volume’s number, name of the journal: write the international acronyms without any punctuation; you must put a space after semicolon and colon (NOT 2014;2014:907915, YES 2014; 2014: 907915); moreover, initial and final pages must be entirely reported (NOT 135-46; YES 135-146). Delete the PMID and DOI number when you have the data aforementioned;

In the references, you must enter a space after semicolon and colon

  • YES: Garcia-Contreras M, Brooks RW, Boccuzzi L, Robbins PD, Ricordi C. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus. Eur Rev Med Pharmacol Sci 2017; 21: 2940-2956.
  • NOT: Garcia-Contreras M, Brooks RW, Boccuzzi L, Robbins PD, Ricordi C. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus. EurRevMedPharmacolSci 2017;21:2940-2956.

In the references, you must substitute “and” with “,” (comma) before the last author’s name;

In the references, all the authors must be written with the same character size. You must write only the first letter in capital letter, without changing the size of them.

(NOT) Example 1: NAINAN OV, XIA G, VAUGHAN G, MARGOLIS HS. Diagnosis of hepatitis A virus infection: A molecular approach. Clinical Microbiology Reviews 2006:19:63-79.

(YES) Example 1: Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 2006; 19: 63-79.

(NOT) Example 2: Ahmad M., Esmeiran H., Alafafsheh A., Al-Ghabeesh S., Al-Hamdan Z. Beliefs and preferred communication channels toward patients with cancer in Jordan. WCRJ 2016;3(3):e753

(YES) Example 2: Ahmad M, Esmeiran H, Alafafsheh A, Al-Ghabeesh S, Al-Hamdan Z. Beliefs and preferred communication channels toward patients with cancer in Jordan. WCRJ 2016; 3: e753.

See also other published articles on our website.

Illustrations

Illustrations and Tables

Figure legends should be included in the main text of the manuscript and not form part of the figures. The authors are encouraged to send the highest-quality figures possible. Click here for Figure details.

For the accepted file format, see below:

Document Files Graphic Files Graphic Files
• Word • GIF
• TIF (or TIFF)
• EPS
• PNG
• JPG (or JPEG)
• BMP
• Quicktime

•  MPEG

• AVI

 

The figure resolution/specification for various types of original figures, at their final size, should be as follows: Line art – Minimum 600 dpi, measuring preferably 13 by 18 cm and no more than 20 by 25 cm in size. Halftone (i.e., both B/W and Colour photographs) – Minimum 300 dpi, measuring preferably 13 by 18 cm and no more than 20 by 25 cm in size. Line and tone (line art and halftone combined) – Minimum 600 dpi, measuring preferably 13 by 18 cm and no more than 20 by 25 cm in size.

For line figures, the lines should be solid, the text in a standard font and not blurred, and the overall image should be sharp and clear. Avoid using tints if possible; if they are essential to the understanding of the figure, try to make them coarse. As a guide, if the electronic files are viewed at 400% on the computer screen and they look blurred or pixelated in any way then they will NOT be of sufficient quality for printing.

Tables should be self-contained and complete; they must not duplicate the information already contained in the text. They should be supplied as editable files (preferably word files), not pasted as images. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for p-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure and table legends must be able to stand alone in the text and thus full descriptive legends for all figures and tables should be supplied.

Units and Abbreviations

All measurements should be in SI units with the exception of hemoglobin (g/dL) and blood pressure (mmHg). Original observations recorded in other units should be stated, together with the appropriate conversion factors. Standard abbreviations, without punctuation, are used. Units, Symbols and Abbreviations (1988) published by the Royal Society of Medicine, and SI: The International System of Units (1982) from HMSO both provide useful guides. Abbreviations, used sparingly, should follow the first full spelling, in parentheses. A list of abbreviations at the beginning of the article is accepted only if they are more than 8.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see http://varnomen.hgvs.org/, where examples of acceptable nomenclature are provided.

Statistics

Methods should be referenced. Two-tailed significance tests should be used unless explicitly stated. Controls should be described as completely as experimental subjects. Measures of location should be accompanied by measures of variability (e.g. mean and confidence intervals) as well as conventional probability values. Clinical trial reports should include the power of the study design.

Ethics

An Ethics Committee should have approved human and animal studies but in questionable matters, the Editors reserve the right to reject papers.

All investigators should ensure that the planning conduct and reporting of human research are in accordance with the Helsinki Declaration. All authors should seek approval to conduct research from an independent local, regional or national review body (e.g., ethics committee, institutional review board). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the local, regional or national review body explicitly approved the doubtful aspects of the study. Approval by a responsible review body does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

Animal Ethics

When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed.

Informed Consent

Appropriate consents, permissions and releases must be obtained where authors wish to include case details or other personal information or images of patients and any other individuals in their publication. This is to comply with all applicable laws and regulations concerning the privacy and/or security of personal information, including, but not limited to the General Data Protection Regulation (GDPR) (EU) 2016/679.

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.

The following statement should be included in each manuscript submitted to our journal:

Informed consent: Informed consent was obtained from all individual participants included in the study.

Some considerations

  • Images of patients or research subjects should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent.
  • If identifying characteristics are altered to protect anonymity, authors should provide assurances that such alterations do not distort scientific meaning.
  • Formal consents are not required for the use of entirely anonymized images from which the individual cannot be identified – for example, x-rays, ultrasound images, laparoscopic images etc.
  • If consent has not been obtained, it is generally not sufficient to anonymize a photograph simply by using eye bars or blurring the face of the individual concerned.

 

Clinical Trials

All clinical trials submitted to WCRJ for consideration of publication must be registered. The International Committee of Medical Journal Editors (ICMJE) defines a clinical trial as “any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials), are exempt.”

For definitions and further information, please see the section titled http://www.icmje.org/about-icmje/faqs/icmje-recommendations/ found in ICMJE’s Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Please note, however, that unlike ICMJE, ADA does not require trials to be registered before enrollment begins, although Diabetes does encourage this practice. When submitting your manuscript, please include the unique trial number and the name of the registry (e.g., ClinicalTrials.gov or ISRCTN) at the end of the abstract and in your cover letter.

Plagiarism or other types of unethical publication practice

Authors who want to publish in our Journal must follow the guidelines on Good Publication Practice as reported in COPE and Council of Science Editors. These guidelines aim to ensure that articles are published in a responsible and ethical manner.

On a practical level, the first thing we do is conduct an early investigation using our anti‐plagiarism software. Our Journal makes a plagiarism checker by a certificate program on all the articles. Also, articles that are related to the suspected case of plagiarism or other unethical practice are checked accuracy by either the reviewer feedback and observations or the Editors own observations. Our anti‐plagiarism software, however, will not identify “salami slicing”. So it is imperative that each case is looked at individually and, therefore, we do not advocate the use of one statement of actions to penalize the offender. Each case is considered separately and, as editors, we will need to decide if it is a deliberate action on the part of the author or it is due to lack of understanding of the requirements of ethical writing. This can happen for new authors or some authors where translation to English is often difficult. An example of this is where there are no words/phrases in that language that translate into English, and a developing practice that we noted is the ‘borrowing’ of words, phrases or often sentences that are considered appropriate for what authors mean to say.

WCRJ disapproves any kind of malpractice and unethical practice.

Financial Support

Sources of financial support during the last two years must be acknowledged. Please read the following statements, adding those sections which are relevant at the end of your submitted manuscript under a heading ‘Statement of Interests’.

  1. Authors’ declaration of personal interests: (i) [Name of individual] has served as a speaker, a consultant and an advisory board member for [names of organizations], and has received research funding from [names of organization]. (ii) [Name of individual] is an employee of [name of organization]. (iii) [Name of individual] owns stocks and shares in [name of organization]. (iv) [Name of individual] owns patent [patent identification and brief description].
  2. Declaration of funding interests: (i) This study was funded [in part or in full] by [insert name of funding organization], grant number [insert grant or other identification numbers]. (ii) The [writing or preparation] of this paper was funded in part by [insert name of funding organization]. (iii) Initial data analyses were undertaken by [name of individuals if not listed as Authors] who are employees of [name company] and received funding from [insert name of funding organization]. (iv) Writing support was provided by [insert name of individual(s)] of [name company] and funded by [insert name of funding organization].

Drug Names

Generic names should, in general, be used. If an Author desires, brand names may be inserted in parentheses. Drug names are spelled out according to the European Pharmacopoeia, but the American spelling should be used after the first use of a drug name.

Revised Articles

Revised articles must be submitted again within 2 months, or else will be considered as rejected.

Galley Proofs

The corresponding Author will receive an e-mail with a PDF file of the galley proof. The galley proof can be downloaded as a PDF (portable document format) file. Acrobat Reader will be required in order to read this file. This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Excessive changes (i.e. over 100 characters) made by the Author to the proofs, excluding typesetting errors, will be charged separately. Changes to figures and tables have an extra cost. Please check carefully the galley proof (especially for what concerns name of Authors, affiliations and corresponding Authors) as after its approval no further change will be possible.

Before the publication, World Cancer Research Journal sends the final galley proof in which only missed misstatements in the previous galley proof can be corrected.

Publishing Schedule

Rather than publishing conventional complete online issues at fixed intervals, starting from January 2019 WCRJ has moved to a continuous publication model, with articles being published on an ongoing basis.

Reprints

Paper reprints shall be charged. Electronic offprints are sent to the first Author at his/her first email address on the title page of the paper, on request. For this reason, please ensure that the name, address and email address of the corresponding Author are clearly indicated on the manuscript title page if he/she is not the first author of the paper.

Supplements

You can contact Gianni Lombardi (g.lombardi@verduci.it). Our team will be able to provide advice and quotations for supplements.

Preservation and Archiving

Our Journal is committed to the permanent availability and preservation of scholarly research and to ensure accessibility by upgrading digital file formats to comply with new technology standards. All our files are archived and preserved in CLOCKSS.